APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ambrisentan Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ambrisentan Drug Market Outlook and Growth Opportunities 2026

20 December 2025193 pages

Choose your research edition.

Industry ResearchAmbrisentan Drug Industry Research Report 2026104 pages · $2,950 USDIndustry Growth & TrendsGlobal Ambrisentan Drug Industry Growth and Trends Forecast to 203261 pages · $3,450 USDMarket StructureGlobal Ambrisentan Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ambrisentan Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Ambrisentan Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ambrisentan Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ambrisentan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ambrisentan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ambrisentan Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ambrisentan Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ambrisentan Drug market include Gilead Sciences, Hansoh Pharma and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Ambrisentan Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ambrisentan Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ambrisentan Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Ambrisentan Drug market.

Ambrisentan Drug Segment by Company

Gilead Sciences

Hansoh Pharma

GSK

Ambrisentan Drug Segment by Type

5 mg Tablet

10 mg Tablet

Ambrisentan Drug Segment by Application

Hospital

Drug store

Ambrisentan Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Ambrisentan Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Ambrisentan Drug key companies, revenue, market share, and recent developments.

3. To split the Ambrisentan Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Ambrisentan Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ambrisentan Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Ambrisentan Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ambrisentan Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ambrisentan Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ambrisentan Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ambrisentan Drug industry.

Chapter 3: Detailed analysis of Ambrisentan Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Ambrisentan Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Ambrisentan Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ambrisentan Drug Industry Trends Table 2. Ambrisentan Drug Industry Drivers Table 3. Ambrisentan Drug Industry Opportunities and Challenges Table 4. Ambrisentan Drug Industry Restraints Table 5. Global Ambrisentan Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ambrisentan Drug Revenue Share by Company (2021-2026) Table 7. Global Ambrisentan Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Ambrisentan Drug Key Company Manufacturing Base & Headquarters Table 9. Global Ambrisentan Drug Company, Product Type & Application Table 10. Global Ambrisentan Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Ambrisentan Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 5 mg Tablet Table 15. Significant Companies of 10 mg Tablet Table 16. Global Ambrisentan Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Ambrisentan Drug Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Ambrisentan Drug Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Ambrisentan Drug Sales Value Share by Type (2021-2026) Table 20. Global Ambrisentan Drug Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Drug store Table 23. Global Ambrisentan Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Ambrisentan Drug Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Ambrisentan Drug Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Ambrisentan Drug Sales Value Share by Application (2021-2026) Table 27. Global Ambrisentan Drug Sales Value Share by Application (2027-2032) Table 28. Global Ambrisentan Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Ambrisentan Drug Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Ambrisentan Drug Sales Value Share by Region (2021-2026) Table 31. Global Ambrisentan Drug Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Ambrisentan Drug Sales Value Share by Region (2027-2032) Table 33. Global Ambrisentan Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Ambrisentan Drug Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Ambrisentan Drug Sales Value Market Share by Country (2021-2026) Table 36. Global Ambrisentan Drug Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Ambrisentan Drug Sales Value Market Share by Country (2027-2032) Table 38. Gilead Sciences Company Information Table 39. Gilead Sciences Business Overview Table 40. Gilead Sciences Ambrisentan Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Gilead Sciences Ambrisentan Drug Product Portfolio Table 42. Gilead Sciences Recent Development Table 43. Hansoh Pharma Company Information Table 44. Hansoh Pharma Business Overview Table 45. Hansoh Pharma Ambrisentan Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Hansoh Pharma Ambrisentan Drug Product Portfolio Table 47. Hansoh Pharma Recent Development Table 48. GSK Company Information Table 49. GSK Business Overview Table 50. GSK Ambrisentan Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. GSK Ambrisentan Drug Product Portfolio Table 52. GSK Recent Development Table 53. Research Programs/Design for This Report Table 54. Authors List of This Report Table 55. Secondary Sources Table 56. Primary Sources List of Figures Figure 1. Ambrisentan Drug Product Image Figure 2. Global Ambrisentan Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ambrisentan Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Ambrisentan Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 5 mg Tablet Image Figure 8. 10 mg Tablet Image Figure 9. Global Ambrisentan Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Ambrisentan Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Ambrisentan Drug Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Drug store Image Figure 14. Global Ambrisentan Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Ambrisentan Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Ambrisentan Drug Sales Value Share by Application (2021-2032) Figure 17. Global Ambrisentan Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Ambrisentan Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Ambrisentan Drug Sales Value (2021-2032) & (US$ Million) Figure 20. North America Ambrisentan Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Ambrisentan Drug Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Ambrisentan Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Ambrisentan Drug Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Ambrisentan Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Ambrisentan Drug Sales Value (2021-2032) & (US$ Million) Figure 26. South America Ambrisentan Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Ambrisentan Drug Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Ambrisentan Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Ambrisentan Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg Tablet
  • 10 mg Tablet
Applications
  • Hospital
  • Drug store
Companies covered
  • Gilead Sciences
  • Hansoh Pharma
  • GSK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ambrisentan Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ambrisentan Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Ambrisentan Drug Market Dynamics
  1. 2.1 Ambrisentan Drug Industry Trends
  2. 2.2 Ambrisentan Drug Industry Drivers
  3. 2.3 Ambrisentan Drug Industry Opportunities and Challenges
  4. 2.4 Ambrisentan Drug Industry Restraints
3 Ambrisentan Drug Market by Company
  1. 3.1 Global Ambrisentan Drug Company Revenue Ranking in 2025
  2. 3.2 Global Ambrisentan Drug Revenue by Company (2021-2026)
  3. 3.3 Global Ambrisentan Drug Company Ranking (2024-2026)
  4. 3.4 Global Ambrisentan Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Ambrisentan Drug Company Product Type and Application
  6. 3.6 Global Ambrisentan Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Ambrisentan Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Ambrisentan Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Ambrisentan Drug Market by Type
  1. 4.1 Ambrisentan Drug Type Introduction
  2. 4.1.1 5 mg Tablet
  3. 4.1.2 10 mg Tablet
  4. 4.2 Global Ambrisentan Drug Sales Value by Type
  5. 4.2.1 Global Ambrisentan Drug Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ambrisentan Drug Sales Value by Type (2021-2032)
  7. 4.2.3 Global Ambrisentan Drug Sales Value Share by Type (2021-2032)
5 Ambrisentan Drug Market by Application
  1. 5.1 Ambrisentan Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug store
  4. 5.2 Global Ambrisentan Drug Sales Value by Application
  5. 5.2.1 Global Ambrisentan Drug Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Ambrisentan Drug Sales Value by Application (2021-2032)
  7. 5.2.3 Global Ambrisentan Drug Sales Value Share by Application (2021-2032)
6 Ambrisentan Drug Regional Value Analysis
  1. 6.1 Global Ambrisentan Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ambrisentan Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Ambrisentan Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Ambrisentan Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ambrisentan Drug Sales Value (2021-2032)
  7. 6.3.2 North America Ambrisentan Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Ambrisentan Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Ambrisentan Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Ambrisentan Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Ambrisentan Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Ambrisentan Drug Sales Value (2021-2032)
  16. 6.6.2 South America Ambrisentan Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Ambrisentan Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Ambrisentan Drug Sales Value Share by Country, 2025 VS 2032
7 Ambrisentan Drug Country-level Value Analysis
  1. 7.1 Global Ambrisentan Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ambrisentan Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Ambrisentan Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Ambrisentan Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Ambrisentan Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Ambrisentan Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Ambrisentan Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Gilead Sciences
  2. 8.1.1 Gilead Sciences Company Information
  3. 8.1.2 Gilead Sciences Business Overview
  4. 8.1.3 Gilead Sciences Ambrisentan Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Gilead Sciences Ambrisentan Drug Product Portfolio
  6. 8.1.5 Gilead Sciences Recent Developments
  7. 8.2 Hansoh Pharma
  8. 8.2.1 Hansoh Pharma Company Information
  9. 8.2.2 Hansoh Pharma Business Overview
  10. 8.2.3 Hansoh Pharma Ambrisentan Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hansoh Pharma Ambrisentan Drug Product Portfolio
  12. 8.2.5 Hansoh Pharma Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Ambrisentan Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GSK Ambrisentan Drug Product Portfolio
  18. 8.3.5 GSK Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst